Katherine Stueland - Mar 26, 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: Chief Executive Officer, Director
Signature: /s/ Bridget Brown, Attorney-in-Fact
Stock symbol: WGS
Transactions as of: Mar 26, 2025
Transactions value $: -$4,451,084
Form type: 4
Date filed: 3/28/2025, 04:07 PM
Previous filing: Mar 11, 2025
Next filing: Apr 10, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+80K	+538.18%	$0.00	94.9K	Mar 26, 2025	Direct	F1
transaction	WGS	Class A Common Stock	Sale	-$4.29M	-44.8K	-47.23%	$95.66	50.1K	Mar 26, 2025	Direct	F2
transaction	WGS	Class A Common Stock	Sale	-$166K	-1.75K	-3.5%	$94.59	48.3K	Mar 26, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-80K	-25%	$0.00	240K	Mar 26, 2025	Class A Common Stock	80K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction
F3	25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.